Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Identification of hypermethylated genes associated with cisplatin resistance in human cancers.

Chang X, Monitto CL, Demokan S, Kim MS, Chang SS, Zhong X, Califano JA, Sidransky D.

Cancer Res. 2010 Apr 1;70(7):2870-9. doi: 10.1158/0008-5472.CAN-09-3427. Epub 2010 Mar 9.

2.

Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.

Zeller C, Dai W, Steele NL, Siddiq A, Walley AJ, Wilhelm-Benartzi CS, Rizzo S, van der Zee A, Plumb JA, Brown R.

Oncogene. 2012 Oct 18;31(42):4567-76. doi: 10.1038/onc.2011.611. Epub 2012 Jan 16.

PMID:
22249249
3.

IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.

Ibanez de Caceres I, Cortes-Sempere M, Moratilla C, Machado-Pinilla R, Rodriguez-Fanjul V, Manguán-García C, Cejas P, López-Ríos F, Paz-Ares L, de CastroCarpeño J, Nistal M, Belda-Iniesta C, Perona R.

Oncogene. 2010 Mar 18;29(11):1681-90. doi: 10.1038/onc.2009.454. Epub 2009 Dec 21.

PMID:
20023704
4.

Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells.

Tanaka T, Bai T, Toujima S, Utsunomiya T, Matsuoka T, Kobayashi A, Yamamoto M, Sasaki N, Tanizaki Y, Utsunomiya H, Tanaka J, Yukawa K.

Oncol Rep. 2012 Apr;27(4):1292-8. doi: 10.3892/or.2012.1628. Epub 2012 Jan 11.

5.

GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling.

Zhang Y, Qu X, Jing W, Hu X, Yang X, Hou K, Teng Y, Zhang J, Liu Y.

Anticancer Drugs. 2009 Mar;20(3):208-14. doi: 10.1097/CAD.0b013e328322fbaa.

PMID:
19396019
6.
7.

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer.

Strathdee G, MacKean MJ, Illand M, Brown R.

Oncogene. 1999 Apr 8;18(14):2335-41.

9.

Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance.

Zhang X, Li W, Li H, Ma Y, He G, Tan G.

Anticancer Drugs. 2012 Sep;23(8):856-64. doi: 10.1097/CAD.0b013e3283548d73.

PMID:
22824824
10.

Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma.

Yamano Y, Uzawa K, Saito K, Nakashima D, Kasamatsu A, Koike H, Kouzu Y, Shinozuka K, Nakatani K, Negoro K, Fujita S, Tanzawa H.

Int J Cancer. 2010 Jan 15;126(2):437-49. doi: 10.1002/ijc.24704.

11.

High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors.

Beyrouthy MJ, Garner KM, Hever MP, Freemantle SJ, Eastman A, Dmitrovsky E, Spinella MJ.

Cancer Res. 2009 Dec 15;69(24):9360-6. doi: 10.1158/0008-5472.CAN-09-1490.

12.

Role of neurofilament light polypeptide in head and neck cancer chemoresistance.

Chen B, Chen J, House MG, Cullen KJ, Nephew KP, Guo Z.

Mol Cancer Res. 2012 Mar;10(3):305-15. doi: 10.1158/1541-7786.MCR-11-0300. Epub 2012 Jan 13.

13.
14.

Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas.

Elias A, Siegelin MD, Steinmüller A, von Deimling A, Lass U, Korn B, Mueller W.

Clin Cancer Res. 2009 Sep 1;15(17):5457-65. doi: 10.1158/1078-0432.CCR-09-1125. Epub 2009 Aug 25.

15.
16.

Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.

Li Z, Zhang H, Yang J, Hao T, Li S.

Cell Biol Int. 2012 May 1;36(5):427-32. doi: 10.1042/CBI20100851.

PMID:
21864295
17.

Codominance of cisplatin resistance in somatic cell hybrids.

Ying YL, Shen DW, Liang XJ, Gottesman MM.

J Cell Physiol. 2003 Jul;196(1):63-9.

PMID:
12767041
18.
19.

5-Aza-2'-deoxycytidine increases the sensitivity of human bone marrow mesenchymal stem cells to chemotherapeutic agents by demethylation of p73.

Liang W, Xia H, Li J, Chunhua Zhao R.

J Pediatr Hematol Oncol. 2012 Mar;34(2):108-15. doi: 10.1097/MPH.0b013e31823e0a87.

PMID:
22278203
20.

Supplemental Content

Support Center